ANAB · Company research
AnaptysBio, Inc. Common Stock (ANAB): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 47.89 | $1,463,241,000 | 1214772000 | — | — | — | 57.2562607606824229 | 114.7910096493292539 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.